In nonalcoholic steatohepatitis, limiting ADAM17 activity increases MerTK expression in macrophages, which further induces TGF-β1 production, leading to the activation of hepatic stellate cells by TGF-β1 to encourage liver fibrosis [63]. Here, ADAM17 is linked to Hepatic fibrosis.